MariMed (XCNQ:MRMD) Inventories, Other : C$0.0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is MariMed Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. MariMed's other inventories for the quarter that ended in Mar. 2024 was C$0.0 Mil.

MariMed's quarterly other inventories stayed the same from Sep. 2023 (C$0.0 Mil) to Dec. 2023 (C$0.0 Mil) but then increased from Dec. 2023 (C$0.0 Mil) to Mar. 2024 (C$0.0 Mil).

MariMed's annual other inventories increased from Dec. 2021 (C$0.0 Mil) to Dec. 2022 (C$0.0 Mil) but then declined from Dec. 2022 (C$0.0 Mil) to Dec. 2023 (C$0.0 Mil).

MariMed Inventories, Other Historical Data

The historical data trend for MariMed's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MariMed Inventories, Other Chart

MariMed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Other

Get a 7-Day Free Trial

MariMed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Other	Get a 7-Day Free Trial															-	-	-	-	-

MariMed Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

MariMed (XCNQ:MRMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MariMed Inc (XCNQ:MRMD) » Definitions » Inventories, Other

Comparable Companies

Traded in Other Exchanges

MRMD:USA

Address

10 Oceana Way, Floor 2, Norwood, MA, USA, 02062

Website

https://www.marimedinc.com

MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees, and Licensing fees.

Executives